Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

BACKGROUND: In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xin, Yang, Xiao-Xu, Ji, Su-Zhen, Wang, Xiao-Zeng, Wang, Li, Gu, Chong-Huai, Ren, Li-Li, Han, Ya-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847352/
https://www.ncbi.nlm.nih.gov/pubmed/27123313
http://dx.doi.org/10.1186/s40779-016-0081-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847352/
https://www.ncbi.nlm.nih.gov/pubmed/27123313
http://dx.doi.org/10.1186/s40779-016-0081-6

Ejemplares similares